Epigenetic Targets and Their Inhibitors in Thyroid Cancer Treatment

Although biologically targeted therapies based on key oncogenic mutations have made significant progress in the treatment of locally advanced or metastatic thyroid cancer, the challenges of drug resistance are urging us to explore other potentially effective targets. Herein, epigenetic modifications...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ke, Wang, Junyao, He, Ziyan, Qiu, Xian, Sa, Ri, Chen, Libo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142462/
https://www.ncbi.nlm.nih.gov/pubmed/37111316
http://dx.doi.org/10.3390/ph16040559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142462/
https://www.ncbi.nlm.nih.gov/pubmed/37111316
http://dx.doi.org/10.3390/ph16040559

Ejemplares similares